
Opinion|Videos|November 22, 2024
Final Thoughts
Key Takeaways
The panel discussion concludes with final thoughts on the future landscape of newly diagnosed multiple myeloma.
Advertisement
Episodes in this series

Advertisement
Latest CME
Advertisement
Advertisement
Trending on Pharmacy Times
1
Medicare Is Finally Covering GLP-1s for Weight Loss: What the Bridge Program Means for Your Practice
2
FDA Narrows Compounding Rules for GLP-1s: How Pharmacists Should Respond
3
Olezarsen Receives FDA Approval to Reduce Triglycerides, Risk of Acute Pancreatitis in Severe Hypertriglyceridemia
4
FDA Grants Fast Track Designation to VS-7375 for KRAS G12D-Mutated Advanced NSCLC
5























































































































